Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Boland

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of Gastrointestinal Oncology|October 3, 2014
The emerging role of neoadjuvant chemotherapy for rectal cancerPatrick M Boland, Marwan Fakih
Cancer|November 12, 2025
Microsatellite instability: Advances in diagnosisPatrick M Boland, Shridar Ganesan
Current Opinion in Oncology|May 18, 2013
Esophageal carcinoma: are modern targeted therapies shaking the rock?Patrick M Boland, Barbara Burtness
Cancers|May 12, 2017
Immunotherapy for Colorectal CancerPatrick M Boland, Wen Wee Ma
Cancers|May 28, 2020
Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, <i>Cancers</i> 2017, <i>9</i>, 50Patrick M Boland, Wen Wee Ma
Journal of the National Cancer Institute|August 25, 2020
Making Fluorouracil "Sexy" AgainPatrick M Boland, Howard S Hochster
Advances in Cancer Research|June 21, 2021
Immunotherapy in colorectal cancerParul Agarwal, Dung T Le, Patrick M Boland
Cancer|February 9, 2017
Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?Srinevas K Reddy, Patrick M Boland, Steven J Nurkin
CA: a Cancer Journal for Clinicians|February 28, 2018
Recent progress in Lynch syndrome and other familial colorectal cancer syndromesPatrick M Boland, Matthew B Yurgelun, C Richard Boland
Familial Cancer|February 21, 2021
Managing gastric cancer risk in lynch syndrome: controversies and recommendationsC Richard Boland, Matthew B Yurgelun, Kathryn A Mraz, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of Gastrointestinal Oncology|October 3, 2014
The emerging role of neoadjuvant chemotherapy for rectal cancerPatrick M Boland, Marwan Fakih
Cancer|November 12, 2025
Microsatellite instability: Advances in diagnosisPatrick M Boland, Shridar Ganesan
Current Opinion in Oncology|May 18, 2013
Esophageal carcinoma: are modern targeted therapies shaking the rock?Patrick M Boland, Barbara Burtness
Cancers|May 12, 2017
Immunotherapy for Colorectal CancerPatrick M Boland, Wen Wee Ma
Cancers|May 28, 2020
Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, <i>Cancers</i> 2017, <i>9</i>, 50Patrick M Boland, Wen Wee Ma
Journal of the National Cancer Institute|August 25, 2020
Making Fluorouracil "Sexy" AgainPatrick M Boland, Howard S Hochster
Advances in Cancer Research|June 21, 2021
Immunotherapy in colorectal cancerParul Agarwal, Dung T Le, Patrick M Boland
Cancer|February 9, 2017
Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?Srinevas K Reddy, Patrick M Boland, Steven J Nurkin
CA: a Cancer Journal for Clinicians|February 28, 2018
Recent progress in Lynch syndrome and other familial colorectal cancer syndromesPatrick M Boland, Matthew B Yurgelun, C Richard Boland
Familial Cancer|February 21, 2021
Managing gastric cancer risk in lynch syndrome: controversies and recommendationsC Richard Boland, Matthew B Yurgelun, Kathryn A Mraz, et al.
Pageof 5